Literature DB >> 32794639

Statistical issues and methods in designing and analyzing survival studies.

Muditha Perera1, Alok Kumar Dwivedi1,2.   

Abstract

BACKGROUND: Cancer studies that are designed for early detection and screening, or used for identifying prognostic factors, or assessing treatment efficacy and health outcome are frequently assessed with survival or time-to-event outcomes. These studies typically require specific methods of data analysis. Appropriate statistical methods in the context of study design and objectives are required for obtaining reliable results and valid inference. Unfortunately, variable methods for the same study objectives and dubious reporting have been noticed in the survival analysis of oncology research. Applied researchers often face difficulties in selecting appropriate statistical methods due to the complex nature of cancer studies. RECENT
FINDINGS: In this report, we describe briefly major statistical issues along with related challenges in planning, designing, and analyzing of survival studies. For applied researchers, we provided flow charts for selecting appropriate statistical methods. Various available statistical procedures in common statistical packages for applying survival analysis were classified according to different objectives of the study. In addition, an illustration of the statistical analysis of some common types of time-to-event outcomes was shown with STATA codes.
CONCLUSIONS: We anticipate that this review article assists oncology researchers in understanding important statistical concepts involved in survival analysis and appropriately select the statistical approaches for survival analysis studies. Overall, the review may help in improving designing, conducting, analyzing, and reporting of data in survival studies.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  statistical methods; survival analysis; time-to-event analysis

Year:  2019        PMID: 32794639      PMCID: PMC7941573          DOI: 10.1002/cnr2.1176

Source DB:  PubMed          Journal:  Cancer Rep (Hoboken)        ISSN: 2573-8348


  39 in total

1.  Tutorial in biostatistics: competing risks and multi-state models.

Authors:  H Putter; M Fiocco; R B Geskus
Journal:  Stat Med       Date:  2007-05-20       Impact factor: 2.373

2.  Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling.

Authors:  Joseph V Terza; Anirban Basu; Paul J Rathouz
Journal:  J Health Econ       Date:  2007-12-04       Impact factor: 3.883

Review 3.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

4.  Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale.

Authors:  E L Korn; B I Graubard; D Midthune
Journal:  Am J Epidemiol       Date:  1997-01-01       Impact factor: 4.897

5.  A jackknife estimator of variance for Cox regression for correlated survival data.

Authors:  S R Lipsitz; M Parzen
Journal:  Biometrics       Date:  1996-03       Impact factor: 2.571

6.  On the prevention and analysis of missing data in randomized clinical trials: the state of the art.

Authors:  Daniel O Scharfstein; Joseph Hogan; Amir Herman
Journal:  J Bone Joint Surg Am       Date:  2012-07-18       Impact factor: 5.284

7.  On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.

Authors:  Hajime Uno; Tianxi Cai; Michael J Pencina; Ralph B D'Agostino; L J Wei
Journal:  Stat Med       Date:  2011-01-13       Impact factor: 2.373

8.  The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2013-09-30       Impact factor: 2.373

9.  Introduction to the Analysis of Survival Data in the Presence of Competing Risks.

Authors:  Peter C Austin; Douglas S Lee; Jason P Fine
Journal:  Circulation       Date:  2016-02-09       Impact factor: 29.690

10.  Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial.

Authors:  Jack Cuzick; Ivana Sestak; Simon Cawthorn; Hisham Hamed; Kaija Holli; Anthony Howell; John F Forbes
Journal:  Lancet Oncol       Date:  2014-12-11       Impact factor: 41.316

View more
  2 in total

Review 1.  Statistical issues and methods in designing and analyzing survival studies.

Authors:  Muditha Perera; Alok Kumar Dwivedi
Journal:  Cancer Rep (Hoboken)       Date:  2019-05-09

2.  Identification of key gene signatures for the overall survival of ovarian cancer.

Authors:  Akash Pawar; Oindrila Roy Chowdhury; Ruby Chauhan; Sanjay Talole; Atanu Bhattacharjee
Journal:  J Ovarian Res       Date:  2022-01-20       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.